Candida colonization index in patients admitted to an ICU

International Journal of Molecular Sciences

Volumn 12, Issue 10, 2011, Pages 7038-7047

  Caggiano, Giuseppina ^a   Puntillo, Filomena ^a   Coretti, Caterina ^a   Giglio, Mariateresa ^a   Alicino, Ilaria ^a   Manca, Fabio ^a   Bruno, Francesco ^a   Montagna, Maria Teresa ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Candida anti mannan antibodies; Candida colonization; Candida mannan; Colonization index

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; MANNAN; POSACONAZOLE; VORICONAZOLE; ANTIBODY; ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA INCONSPICUA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; HOSPITAL ADMISSION; HUMAN; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; KLUYVEROMYCES MARXIANUS; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ADOLESCENT; BLOOD; CANDIDIASIS; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NEUROLOGIC DISEASE; PATHOLOGY; TIME; VERY ELDERLY; YOUNG ADULT;

CANDIDA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIGENS; CANDIDA; CANDIDIASIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 80055027356     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12107038     Document Type: Article

References (28)

1. Caggiano, G.; Iatta, R.; Laneve, A.; Manca, F.; Montagna, M.T. Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004. Mycoses 2008, 51, 123-128.
2. Zaoutis, T.E.; Prasad, P.A.; Localio, A.R.; Coffin, S.E.; Bell, L.M.; Walsh, T.J.; Gross, R. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin. Infect. Dis. 2010, 51, 38-45.
3. Pfaller, M.A.; Diekema, D.J. Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev. 2007, 20, 133-163.
4. Bouza, E.; Muñoz, P. Epidemiology of candidemia in intensive care units. Int. J. Antimicrob. Agents 2008, 32, 87-91.
5. Eggimann, P.; Garbino, J.; Pittet, D. Epidemiology of Candida species infections in critically ill non immunosuppressed patients. Lancet Infect. Dis. 2003, 3, 685-702.
6. Klempp-Selb, B.; Rimek, D.; Kappe, R. Karyotiping of Candida albicans and Candida glabrata from patients with Candida sepsis. Mycoses 2000, 43, 159-163.
7. Singhi, S.; Rao, D.S.; Chakrabarti, A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr. Crit. Care Med. 2008, 9, 91-95.
8. Ruping, M.J.; Vehreschild, J.J.; Cornely, O.A. Patients at high risk of invasive fungal infection: when and how to treat. Drugs 2008, 68, 1941-1962.
9. Wey, S.B.; Mori, M.; Pfaller, M.A.; Woolson, R.F.; Wenzel, R.P. Risk factors for hospitalacquired candidemia. A matched case-control study. Arch. Int. Med. 1989, 149, 2349-2353.
10. Agvald-Ohman, C.; Klingspor, L.; Hjelmqvist, H.; Edlund, C. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand. J. Infect. Dis. 2008, 40, 145-153.
11. Almirante, B.; Rodríguez, D.; Park, B.J.; Cuenca-Estrella, M.; Planes, A.M.; Almela, M.; Mensa, J.; Sanchez, F.; Ayats, J.; Gimenez, M.; et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J. Clin. Microbial. 2005, 43, 1829-1835.
12. Charles, P.E.; Dalle, F.; Aube, H.; Doise, J.M.; Quenot, J.P.; Aho, L.S.; Chavanet, P.; Blettery, B. Candida spp. colonization significance in critically ill medical patients: A prospective study. Intensive Care Med. 2005, 31, 393-400.
13. Paphitou, N.I.; Ostrosky-Zeichner, L.; Rex, J.H. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: Approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med. Mycol. 2005, 43, 235-243.
14. Petri, M.G.; Konig, J.; Moecke, H.P. Epidemiology of invasive mycosis in ICU patients: A prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med. 1997, 23, 317-325.
15. Slotman, G.; Shapiro, E.; Moffa, S. Fungal sepsis: multisite colonization versus fungemia. Am. Surg. 1994, 60, 107-113.
16. Pittet, D.; Monod, M.; Suter, P.M.; Frenk, E.; Auckenthaler, R. Candida colonization and subsequent infections in critically ill surgical patients. Ann. Surg. 1994, 220, 751-758.
17. Clinical and Laboratory Standard Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, 2nd ed.; Clinical and Laboratory Standard Institute: Wayne, PA, USA, 2008; CLSI Document M38-A2.
18. Pfaller, M.A. Diekema, D.J.; Jones, R.N.; Sader, H.S.; Fluit, A.C.; Hollis, R.J.; Messer, S.A.; SENTRY Participant Group. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 2001, 39, 3254-3259.
19. Diekema, D.J.; Messer, S.A.; Boyken, L.B.; Hollis, R.J.; Kroeger, J.; Tendolkar, S.; Pfaller, M.A. In vitro activity of seven systemically active antifungal agents against a large global rare Candida species as determined by CLSI broth microdilution methods. J. Clin. Microbiol. 2009, 47, 3170-3177.
20. Garbino, J.; Lew, D.P.; Romand, J.A.; Hugonnet, S.; Auckenthaler, R.; Pittet, D. Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients. A randomized, double-blind, placebo-controlled trial in SDD-treated patients. Intensive Care Med. 2002, 28, 1708-1717.
21. Dubau, B.; Triboulet, C.; Winnock, S. Utilisation pratique de l'index de colonisation. Ann. Fr. Anesth. Reanim. 2001, 20, 418-420.
22. Ellis, M.; Al-Rmandi, B.; Bernsen, R.; Kristensen, J.; Alizadeh, H.; Hedstrom, U. Prospective evaluation of mannan and anti-manna antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J. Med. Microbiol. 2009, 58, 606-615.
23. Laín, A.; Elguezabal, N.; Moragues, M.D.; García-Ruiz, J.C.; Del Palacio, A.; Pontón, J. Contribution of serum biomarkers to the diagnosis of invasive candidiasis. Expert Rev. Mol. Diagn. 2008, 8, 315-325.
24. Pontón, J. Usefulness of biological markers in the diagnosis of invasive candidiasis. Rev. Iberoam. Micol. 2009, 26, 8-14.
25. Prella, M.; Bille, J.; Pugnale, M.; Duvoisin, B.; Cavassini, M.; Calandra, T.; Marchetti, O. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn. Microbiol. Infect. Dis. 2005, 51, 95-101.
26. Shea, Y.R. Algorithms for Detection and Identification of Fungi. In Manual of Clinical Microbiology, 9th ed.; Murray, P., Baron, E.J., Jorgensen, J., Landry, M.L., Pfaller, M., Eds. ASM Press: Washington, DC, USA, 2007; pp. 1745-1761.
27. Sendid, B.; Poirot, J.L.; Tabouret, M.; Bonnin, A.; Caillot, D.; Camus, D.; Poulain, D. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol. 2002, 51, 433-442.
28. Sendid, B.; Caillot, D.E.; Baccouch-Humbert, B.; Klingspor, L.; Grandjean, M.; Bonnin, A.; Poulain, D. Contribution of the Platelia Candida Specific Antibody and Antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J. Clin. Microbiol. 2003, 41, 4551-4558.